IP Library Granted Patent US 8,129,116
Granted Patent B2
US 8,129,116 · App. 12/785,974 · Granted Mar 6, 2012

Methods for nucleic acid manipulation

Assignee: The Penn State Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,129,116
App. No.
12/785,974
Granted
Mar 6, 2012
Kind
B2
Abstract

A method for replicating and amplifying a target nucleic acid sequence is described. A method of the invention involves the formation of a recombination intermediate without the prior denaturing of a nucleic acid duplex through the use of a recombination factor. The recombination intermediate is treated with a high fidelity polymerase to permit the replication and amplification of the target nucleic acid sequence. In preferred embodiments, the polymerase comprises a polymerase holoenzyme. In further preferred embodiments, the recombination factor is bacteriophage T4 UvsX protein or homologs from other species, and the polymerase holoenzyme comprises a polymerase enzyme, a clamp protein and a clamp loader protein, derived from viral, bacteriophage, prokaryotic, archaebacterial, or eukaryotic systems.

Claims (20)

1. A composition for amplifying a target nucleic acid sequence comprising:

(a) bacteriophage T4 UvsX protein

(b) two primers that are complementary to the flanking ends of said target nucleic acid sequence, and

(c) a polymerase.

2. A composition according to claim 1 , further comprising bacteriophage T4 UvsY protein.

3. A composition according to claim 1 , wherein said polymerase is a polymerase holoenzyme.

4. A composition according to claim 3 , wherein said polymerase holoenzyme comprises a polymerase enzyme, a clamp protein, and a clamp loader protein.

5. A composition according to claim 1 , further comprising nucleotide triphosphates in amounts sufficient to permit amplification of said target nucleic acid sequence.

6. A composition according to claim 1 , further comprising said target nucleic acid sequence.

7. A composition according to claim 1 , further comprising bacteriophage T4 gene product 32 protein.

8. A composition according to claim 1 , wherein said primers are present in a molar excess relative to said target nucleic acid sequence.

9. A method for amplifying a target nucleic acid comprising contacting said target nucleic acid sequence with the composition of claim 1 .

10. A composition according to claim 1 , further comprising a helicase.

11. A composition according to claim 10 , wherein said helicase is bacteriophage T4 gene product 41 DNA helicase.

12. A composition according to claim 10 , wherein said helicase is bacteriophage T4 replicative helicase complex, comprising bacteriophage T4 gene product 41 and gene product 59.

13. A composition for amplifying a target nucleic acid sequence comprising:

(a) bacteriophage T4 UvsX protein

(b) two primers that are complementary to the flanking ends of said target nucleic acid sequence

(c) a polymerase, and

(d) a helicase.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 17, 2013
From: BENKOVIC, STEPHEN J; SALINAS, FRANK
To: THE PENN STATE RESEARCH FOUNDATION
Reel/Frame 030626/0734 →
CONFIRMATORY LICENSE Recorded Jun 28, 2010
From: PENNSYLVANIA STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024600/0255 →
Continuity (4)
Continuation 11204125 · Aug 15, 2005
Continuation 10125973 · Apr 19, 2002
Provisional Application 60285127 · Apr 20, 2001
Related Publication 20100279357A1 · Nov 4, 2010